Dr Renata Libianto is a PhD student in the Endocrine Hypertension Research Group and a clinical Endocrinologist. Her current research projects aim to investigate the prevalence of primary aldosteronism, an important cause of secondary hypertension, in the community, and identify novel biomarkers that can facilitate the diagnosis.

Selected publications

  • Chee NYN, Abdul-Wahab A, Libianto R, Gwini SM, Doery JCG, Choy KW, Chong W, Lau KK, Lam Q, MacIsaac RJ, Chiang C, Shen J, Young MJ, Fuller PJ, Yang J. (2020) Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization. Clinical Endocrinology 2020 May 13. doi: 10.1111/cen.14220.

  • Libianto R, Fuller PJ, Young M, Yang J (2020) Primary aldosteronism is a public health issue: challenges and opportunities. Journal of Human Hypertension 34,478–486. https://doi.org/10.1038/s41371-020-0336-2.

  • Lim YY, Libianto R, Shen J, Young MJ, Fuller PJ, Yang J (2020) Impact of Victoria’s first dedicated Endocrine Hypertension Service on the pattern of primary aldosteronism diagnoses. Internal Medicine Journal 2020 May 3. doi: 10.1111/imj.14879.